期刊
JOURNAL OF CONTROLLED RELEASE
卷 296, 期 -, 页码 162-178出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2019.01.023
关键词
Drying technology; Colon targeting; Targeted delivery; Oral delivery; Biopharmaceuticals; Freeze drying; Spray drying; Electrospinning
资金
- OTKA [K-112644, PD-128241, KH-124541]
- grant BME FIKP-BIO by EMMI
In chronic intestinal diseases like inflammatory bowel disease, parenteral administration of biopharmaceuticals is associated with numerous disadvantages including immune reactions, infections, low patient compliance, and toxicity caused by high systemic bioavailability. One alternative that can potentially overcome these limitations is oral administration of biopharmaceuticals, where the local delivery will reduce the systemic exposure and furthermore the manufacturing costs will be lower. However, the development of oral dosage forms that deliver the biologically active form to the intestines is one of the greatest challenges for pharmaceutical technologists due to the sensitive nature of biopharmaceuticals. The present article discusses the various drug delivery technologies used to produce orally administered solid dosage forms of biopharmaceuticals with an emphasis on colon-targeted delivery. Solid oral dosage compositions containing different types of colon-targeting biopharmaceuticals are compiled followed by a review of currently applied and emerging drying technologies for biopharmaceuticals. The different drying technologies are compared in terms of their advantages, limitations, costs and their effect on product stability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据